Scarica l'app Stockscreener
10.21
0.20%
-0.02
Dopo l'orario di chiusura:
10.21
Precedente Chiudi:
$10.23
Aprire:
$10.21
Volume 24 ore:
20,799
Relative Volume:
1.90
Capitalizzazione di mercato:
$219.49M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$10.21
$10.25
Intervallo di 1 settimana:
$10.20
$10.35
Portata 52W:
$10.20
$10.35
Helix Acquisition Corp Iii Stock (HLXC) Company Profile
Nome
Helix Acquisition Corp Iii
Settore
Industria
Telefono
-
Indirizzo
-
Confronta HLXC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HLXC
Helix Acquisition Corp Iii
|
10.21 | 219.92M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
9.44 | 2.75B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
XXI
Twenty One Capital Inc
|
7.60 | 2.63B | 0 | 0 | 0 | 0.00 |
|
CCCX
Churchill Capital Corp X
|
13.50 | 804.69M | 0 | 0 | 0 | 0.00 |
|
DMII
Drugs Made In America Acquisition Ii Corp
|
9.97 | 653.13M | 0 | 0 | 0 | 0.00 |
|
CEPF
Cantor Equity Partners Iv Inc
|
10.47 | 597.79M | 0 | 0 | 0 | 0.00 |
Helix Acquisition Corp Iii Borsa (HLXC) Ultime notizie
Helix Acquisition Corp. III completes $172.5 million IPO and private placement - Investing.com
Helix Acquisition Corp. III Completes Initial Public Offering - TradingView
Finance Watch: SPACs Attempt A Comeback As IPO Market Shows Signs Of Life - Citeline News & Insights
With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma - Institutional Investor
Helix Acquisition prices $150M initial public offering - MSN
Will Helix Acquisition Corp. II stock continue dividend increasesRate Cut & AI Forecast Swing Trade Picks - mfd.ru
Helix Acquisition Corp. III raises $172.5 million in Nasdaq IPO By Investing.com - Investing.com Nigeria
Helix Acquisition Corp III closes $172.5 million IPO By Investing.com - Investing.com South Africa
Helix Acquisition Corp. III closes $172.5 million IPO By Investing.com - Investing.com Australia
Helix Acquisition Corp. III raises $172.5 million in Nasdaq IPO - Investing.com
Helix Acquisition Corp. III closes $172.5 million IPO - Investing.com India
Helix Acquisition Corp. III Announces Closing of $172.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares - The Manila Times
SL Green Realty Corp. Announces Date of 2026 Annual Meeting of Stockholders - The Manila Times
White & Case advises Helix Acquisition Corp. III on upsized US$150 million IPO - White & Case LLP
Biotech investor Cormorant secures $150M for another SPAC deal - BioPharma Dive
Helix Acquisition III Raises $150 Million, Targets Healthcare Sector - Intellectia AI
Helix Acquisition Corp. III Prices Upsized $150 Mln IPO - Nasdaq
Helix Acquisition Corp. III Announces Pricing of Upsized $150 Million Initial Public Offering - The Manila Times
Helix Acquisition III launches $150M healthcare-focused SPAC IPO - Stock Titan
Day One was one of three parties interested in Mersana; Bihua Chen and Cormorant’s third SPAC - Endpoints News
HLXC IPO NewsCormorant's SPAC Helix Acquisition III files for a $125 million IPO, targeting healthcare - renaissancecapital.com
BBOT Debuts as a Publicly Traded Company Focused on - GlobeNewswire
BridgeBio Oncology Lands Massive $382M SPAC Deal as Top Investors Back Cancer Drug Pipeline - Stock Titan
BridgeBio Oncology's SPAC Merger Advances: SEC Clears Path for Novel Cancer Drug Development Platform - Stock Titan
Longevity Biotech Takes Root on Nasdaq With $180M SPAC Deal - BioSpace
Helix Acquisition Corp. II SEC 10-Q Report - TradingView
Swiss ADC Biotech Takes SPAC Track to NASDAQ - BioSpace
BridgeBio Oncology and Helix enter definitive merger agreement - Pharmaceutical Technology
BridgeBio spinout to go public in SPAC deal (HLXB:NASDAQ) - Seeking Alpha
Life Sciences Hedge Fund Perceptive Preps a New SPAC - Institutional Investor
Helix Acquisition Corp. II Closes of $184 Million IPO - citybiz
Helix Acquisition Corp. II Prices of Upsized $160 Million IPO - citybiz
Cormorant Launches Second SPAC Following MoonLake Deal with $100M IPO - BioSpace
MoonLake Immunotherapeutics AG and Helix Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing Tri-specific Nanobody® Sonelokimab - Business Wire
Helix Acquisition Corp Iii Azioni (HLXC) Dati Finanziari
Non sono disponibili dati finanziari per Helix Acquisition Corp Iii (HLXC). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.64%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):